Showing results (11-20 of 238) with videos related to
Sort By:
Pageof 24
Nature Reviews. Clinical Oncology|February 4, 2010
Management of breast cancer with targeted agents: importance of heterogeneity. [corrected]Serena Di Cosimo, José BaselgaThe Journal of Clinical Investigation|October 4, 2011
Targeted therapies for breast cancerMichaela J Higgins, José BaselgaCancer Discovery|September 13, 2012
Whole-genome sequencing and cancer therapy: is too much ever enough?Levi A Garraway, José BaselgaNature Reviews. Clinical Oncology|February 1, 2011
Breast cancer in 2010: Novel targets and therapies for a personalized approachMichaela J Higgins, José BaselgaClinical Breast Cancer|December 15, 2010
CLEOPATRA: a phase III evaluation of pertuzumab and trastuzumab for HER2-positive metastatic breast cancerJosé Baselga, Sandra M SwainJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2005
Critical update and emerging trends in epidermal growth factor receptor targeting in cancerJosé Baselga, Carlos L ArteagaNature Reviews. Cancer|June 19, 2009
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3José Baselga, Sandra M SwainEuropean Journal of Cancer (Oxford, England : 1990)|November 18, 2008
Targeted therapies in breast cancer: where are we now?Serena Di Cosimo, José BaselgaClinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2012
Impact of genomics on personalized cancer medicineCarlos L Arteaga, José BaselgaClinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2016
Molecular Pathways: AXL, a Membrane Receptor Mediator of Resistance to TherapyMaurizio Scaltriti, Moshe Elkabets, José BaselgaPageof 24